pic01Late last month, the Supreme Court decided an interesting case at the very cusp of what constitutes a copyright-eligible design as opposed to an ineligible article of manufacture.  See Star Athletica, LLC v. Varsity Brands, Inc. (No. 15-866).  In 2010, the cheerleading clothing outfit behemoth Varsity Brands claimed that a competitor, Star Athletica, copied several of its cheerleading outfit designs (e.g., chevrons, stripes, etc.) and sued Star for copyright infringement under 17 U.S.C. §101 of The Copyright Act of 1976.  The Act mandates that “the design of a useful article” is eligible for copyright if “such design incorporates pictorial, graphic, or sculptural features that can be identified separately from, and are capable of existing independently of, the utilitarian aspects of the article.”1  This aspect of the Act is commonly referred to as the “separate – identification and independent – existence” requirement or, put simply, the “Separability Test”.  Varsity argued that since cheerleading uniforms (“the useful article”) could either contain or lack superficial designs, the designs themselves are in fact separate graphic works that make uniforms unique and are therefore subject to copyright protection.  Counter to this position, Star claimed that the designs on a cheerleading uniform are inherent to the uniform and are not stand-alone, separate design elements.

Initially, the District Court sided with Star.  After an appeal by Varsity, the Sixth Circuit of the United States Court of Appeals reversed the decision.  Subsequently, the Supreme Court granted certiorari in order to resolve the issue.  In a 6-2 decision, the Supreme Court sided with Varsity, citing that its argument was in agreement with §101.  Although not a trivial decision, this significant ruling helps to further clarify the implementation of the Separability Test and, thus, the circumstances under which copyright law can be applied to design protection.

1 https://www.copyright.gov/title17/chapter1.pdf

-David Puleo and Anthony D. Sabatelli, PhD, JD

David Puleo is a Ph.D. Candidate in the Pharmacology Department at Yale University. He is currently involved in two drug discovery projects targeting tyrosine kinases. Prior to attending Yale, David graduated from Boston College with a B.S. in Biochemistry, after which he worked for two years in the Center for Proteomic Chemistry at Novartis Institutes for BioMedical Research in Cambridge, MA.

This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. The opinions expressed in this article are those of the author only and are not necessarily shared by Dilworth IP, its other attorneys, agents, or staff, or its clients.